Nipro PharmaPackaging announced today that it launched new D2F (direct-to-fill) glass vials powered by Stevanato Group technology. The vials feature Stevanato’s EZ-fill technology to offer a high-quality, ready-to-use (RTU) solution. Nipro designed the vials to meet the rigorous standards and increasing requirements of the pharmaceutical industry. D2F vials are washed, depyrogenated, packaged in nest and…

PCI Pharma Services announced that it’s investing more than $365 million in infrastructure to support assembly and packaging efforts. The investment supports the clinical- and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. PCI Pharma plans to put its investment toward new and…

Wheeler Bio announced today that it expanded its capabilities through the licensing of ATUM’s miFuc platform. ATUM designed miFuc for the expression of recombinant proteins containing afucosylated glycans. The technology supports the development of antibodies with a significant reduction in fucosylation without affecting product titer, cellular growth rates or incurring global glycan liabilities. ATUM’s proprietary…

Pharma giants Sanofi and Novartis came in at No. 7 and 17, respectively, in Time magazine’s “Most Sustainable Companies of 2024” rankings. Overall, nearly 40 of the 500 companies on the list fell under the category of Chemicals, Drugs & Biotechnology. Other large pharma companies making it into the top half of the 500 included…

When it comes to drug development and manufacturing, operational excellence (OpEx) is critical for success at all levels. It can help establish a culture of continuous improvement and innovation while supporting data quality, compliance, customer satisfaction, and more. It can even impact external perceptions of the company and confidence in the strength of the business.…

As 2023 draws to a close, the pharma industry finds itself at an inflection point. On the one hand, stubbornly high inflation rates, a dearth of talent, supply chain hurdles, and a more challenging regulatory climate threaten profitability. But on the other, the rapid advances in areas ranging from cell and gene therapy and IT…

Heading into 2024, the pharma industry finds itself in uncharted waters. On the one hand, the sector’s commitment to R&D investment and innovation output is likely to remain strong, with tools based on AI, automation and real-world data promising more streamlined drug candidate optimization. Additionally, the pharma sector is typically resilient in economic downturns. Financial…

With the rise of biologics and personalized medicine, the biopharmaceutical industry is adding single-use technologies (SUTs) to their manufacturing options. Manufacturers are realizing the benefits of being agile, and many are adopting SUTs to turn over smaller batches of new products quickly and efficiently. Single-use technologies use disposable bioprocessing equipment, such as bags and flexible…

Digitalization empowers pharmaceutical companies to bring therapies to patients faster by using advanced analytics strategies to profitably optimize manufacturing operations. In the pharmaceutical industry, operational issues from efficiency losses to failed batches can delay delivery of potentially lifesaving therapies to patients. For this and other reasons, pharmaceutical organizations require resources dedicated to batch prediction, planning…

Single-use instrumentation, especially new pH sensors designed for upstream and downstream applications, are helping manufacturers develop production suites for creating a greater variety of small-run yet highly targeted drugs. Life sciences manufacturers already incorporate leading measurement and automation technologies to ensure the quality of the drugs and medicines they bring to market. Yet because the…